The compound was synthesized for Cerepeut Inc. by the Chemistry Branch of Medicilon.

Part of the compound synthesis was performed at Medicilon.

BAY-1834845 and PF-06650833 are synthesize by Medicilon.

2023年美國化學(xué)學(xué)會(huì)秋季會(huì)議與博覽會(huì)(ACS FALL 2023)由美國化學(xué)學(xué)會(huì)(American Chemical Society, ACS)主辦。美迪西國際研發(fā)服務(wù)部執(zhí)行副總裁戴學(xué)東博士將出席大會(huì)，并帶領(lǐng)美迪西美國團(tuán)隊(duì)一起亮相ACS FALL 2023。

The methylase METTL3 is the writer enzyme of the N6‐methyladenosine (m6A) modification of RNA.Here researchers report a nanomolar inhibitor of METTL3 (UZH1a) which is selective and cell‐permeable, whi

zapERtrap opens the door to previously unapproachable questions concerning how proteins are processed, trafficked, and secreted in space and time in complex cellular environments. zapERtrap relies on

Hypertension is a serious public health problem worldwide. MT-1207 is a chemical entity that has entered into clinical trial as antihypertensive agent. MT-1207 potently inhibits adrenergic α1A, α1B, α

OHD (purity >99 %) was synthesized by Medicilon. Medicilon synthetic chemistry team is capable of the independent design of synthesis pathways and complex compound treatments, key to helping accelerate drug discovery.

美國化學(xué)會(huì)秋季年會(huì)于2022.8.21拉開帷幕，美迪西美國團(tuán)隊(duì)將全程出席此次論壇，歡迎到展位號(hào)#325與我們現(xiàn)場(chǎng)交流！美國化學(xué)會(huì)（American Chemical Society）由美國國會(huì)于1876年特許成立，是世界上最大的科學(xué)學(xué)會(huì)，該學(xué)會(huì)旨在推動(dòng)更廣泛的化學(xué)企業(yè)及其從業(yè)者通過化學(xué)的轉(zhuǎn)化力量來改善人們的生活， ACS提供化學(xué)及相關(guān)領(lǐng)域的信息、教育、職業(yè)等多種服務(wù)。